tiprankstipranks
Medicinova (NASDAQ:MNOV) Rises on Key Patent Win in Europe
Market News

Medicinova (NASDAQ:MNOV) Rises on Key Patent Win in Europe

Story Highlights

Medicinova has bagged a key patent for tipelukast in Europe. The milestone comes after the company recently also bagged a similar patent in Canada.

Shares of biopharmaceutical company Medicinova (NASDAQ:MNOV) are surging upward today after it bagged a Decision to Grant for a new patent from the European Patent Office for its small molecule compound tipelukast (MN-001). This compound is for the treatment of scleroderma, which involves skin tightening and hardening, and systemic sclerosis, which can mean scar tissue build-up in the skin as well as other organs.

The allowed claims under the patent cover oral administration as well as liquid dosage and the validity of the patent stands until June 2035. The allotment is based on positive results from a recent systemic sclerosis animal model study.

The company has already bagged a similar patent in Canada earlier this year and the patent win in Europe could potentially boost the value of MN-001.  Importantly, the drug has received a fast-track designation for the treatment of NASH (nonalcoholic steatohepatitis) with fibrosis as well as fast-track and orphan drug designation for the treatment of idiopathic pulmonary fibrosis.

Despite today’s price gains, Medicinova shares are still down nearly 5.3% over the past 52 weeks.

Read full Disclosure

Tired of arriving late to the Big Returns Party?​
Most investors don’t have major gainers like TSLA or NVDA on their radar from the start.
The profusion of opinions on social media and financial blogs makes it impossible to distinguish between real growth potential and pure hype.
​​For the past decade, we have developed and perfected technology designed to help private investors, just like you, find the best opportunities, with the greatest upside potential, in any financial climate.​
Learn More
Medicinova (NASDAQ:MNOV) Rises on Key Patent Win in Europe
News On DemandStay up-to-date on market-moving news with a feed made just for youGet the App

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100
RUT
Russell 2000
TNX
10-Yr-Bond
Bitcoin

Popular Articles